Benzinga's Top Pre-Market Gainers
CardioNet (NASDAQ: BEAT) soared 46.73% to $4.71 in the pre-market trading after the company entered into an agreement with UnitedHealthcare Insurance.
Questcor Pharmaceuticals (NASDAQ: QCOR) moved up 16.45% to $42.75 in the pre-market session after the company acquired rights to develop Synacthen®.
Vanda Pharmaceuticals (NASDAQ: VNDA) surged 3.98% to $10.45 in the pre-market session. Vanda Pharmaceuticals shares have jumped 138.15% over the past 52 weeks, while the S&P 500 index has gained 24.06% in the same period.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.